Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT04164199
Title Study of Tislelizumab and/or Pamiparib Containing Treatments in Participants With Advanced Malignancies
Recruitment Enrolling by invitation
Gender both
Phase Phase III
Variant Requirements No
Sponsors BeiGene
Age Groups: senior | adult
Covered Countries

No variant requirements are available.